October 5, 2026

Penumbra, Inc. (PEN) Investor Outlook: Exploring the 13.95% Potential Upside Amid Strong Revenue Growth

Penumbra, Inc. (PEN), a key player in the medical devices sector, has been catching the eye of investors with its robust growth prospects and innovative product offerings. With a market..

Doximity, Inc. (DOCS) Stock Analysis: Exploring Its 6.22% Potential Upside

Doximity, Inc. (NYSE: DOCS) stands as a noteworthy player in the healthcare sector, particularly within the niche of Health Information Services. This San Francisco-based company has carved out a significant..

Baxter International (BAX) Investor Outlook: 22% Upside Potential Amid Mixed Valuation Metrics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector specializing in medical instruments and supplies, is positioned at an intriguing juncture for investors. With a market capitalization of..

GSK plc (GSK) Stock Analysis: Unveiling a 26% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a leading player in the healthcare sector, is positioned in the drug manufacturing industry with a robust market capitalization of $94.23 billion. Known for its extensive..

DaVita Inc. (DVA) Stock Analysis: Uncovering a 23% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector specializing in kidney dialysis services, has been attracting attention from investors due to its significant potential upside and robust performance..

Humana Inc. (HUM) Stock Analysis: Navigating Growth with a Potential 9.11% Upside

Humana Inc. (HUM), a prominent player in the healthcare sector, has been making waves with its comprehensive range of insurance and health services. With a market capitalization of $46.63 billion,..

ResMed Inc. (RMD) Stock Analysis: Assessing a Potential 14% Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly in the field of medical instruments and supplies, is garnering attention due to its solid market presence and..

Edwards Lifesciences Corporation (EW) Investor Outlook: A Promising 18.57% Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a titan in the healthcare sector with a commanding $49.03 billion market capitalization, continues to capture investor interest with its innovative solutions in the medical..

Genmab A/S (GMAB) Stock Analysis: Exploring a 15% Potential Upside in Biotechnology

Genmab A/S (GMAB), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline of antibody-based treatments and strategic collaborations. Headquartered in Copenhagen, Denmark, Genmab..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 21% Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves among investors with a compelling growth narrative. Headquartered in Basel, Switzerland, the company is renowned for..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Robust Growth Potential with a 35% Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling investment opportunity. With a market capitalization of $40.89..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Robust Healthcare Giant with a 2.50% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to captivate investors with its strong market presence and innovative therapeutic solutions. With a market capitalization of $217.9 billion,..

The Cooper Companies, Inc. (COO): Investor Outlook Highlights 16% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, stands at a crossroads of potential growth and stability, offering a compelling proposition for investors eyeing the..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth with an 8.54% Upside Potential

As a titan in the healthcare sector, McKesson Corporation (NYSE: MCK) stands as a pivotal player in medical distribution. With a robust market capitalization of $105.2 billion, McKesson’s presence is..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Targeted Growth with a 15% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), headquartered in Tel Aviv-Yafo, Israel, stands as a key player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic industry. With..

Insulet Corporation (PODD) Stock Analysis: Assessing a 30% Upside in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector, particularly within the dynamic medical devices industry, as a compelling opportunity for investors seeking exposure to innovative diabetes management solutions...

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Powerhouse with 11.82% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare diagnostics and research industry, presents a compelling case for investors seeking growth in the sector. With a market capitalization of..

Centene Corporation (CNC) Stock Analysis: Evaluating a 13.95% Upside Potential in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare plans industry, offering managed care services across diverse segments such as Medicaid, Medicare, and Commercial. With a market..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 34.32% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Koninklijke Philips N.V. (NYSE: PHG), a leading name in the medical devices industry. With a..

Pfizer, Inc. (PFE) Stock Analysis: A Healthcare Giant with a Robust 6.19% Dividend Yield and Strategic Collaborations

Pfizer Inc. (NYSE: PFE), a cornerstone in the healthcare sector, continues to capture investor attention with its impressive dividend yield and strategic partnerships. As a leading player in the drug..

Search

Funds

October 5, 2026

Search

Funds

October 5, 2026

FTSE 100

Funds